Table 1.
Platform | Method | Read length [bp] | Read type | Advantages | Disadvantages | Refs. |
---|---|---|---|---|---|---|
Second‐generation sequencing | ||||||
Illumina MiSeq | Sequencing by synthesis and reversible termination | 150, 250 | PE | The read length is relatively long | The sequencing results were obtained in 24–36 h, low throughput | [ 196 , 215 ] |
Illumina NextSeq500/550 | 75, 150 | SE, PE | The sequencing results were obtained in 11–29 h | Short read length | [ 25 , 26 , 236 ] | |
Illumina HiSeq 4000 | 125, 150 | PE | High throughput and long read length | The sequencing results were obtained in 84 h | [ 21 , 25 ] | |
Illumina NovaSeq 600 | 150 | PE | High throughput and long read length | The sequencing results were obtained in 40 h | [ 237 , 238 ] | |
BGISEQ‐50 | Combinatorial probe anchor ligation and DNA nanoball | 50 | SE | Low cost, received medical device certification clearance | Short read length | [ 24 , 132 , 239 ] |
BGISEQ‐100 | 50 | SE | Low cost | [ 29 , 30 ] | ||
MGISEQ‐2000 | 100 | PE | Low cost, received medical device certification clearance | [ 240 , 241 ] | ||
Third‐generation sequencing | ||||||
PacBio Sequel | Single molecule real time (SMRT) sequencing | 1–1.8 kb | SE | Long read length | Low accuracy and high cost | [ 242 ] |
Oxford Nanopore MinION | Nanopore sequencing | / | 1D | Long read length and rapid sequence time | Low accuracy and high cost | [ 174 ] |
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.